The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Taubert Jennifer L since 2019.
This trader's CIK number is 1745938.
At the time of last reporting, Taubert Jennifer L was the EVP, WWC. Innovative Medicine of Johnson & Johnson. (stock ticker symbol JNJ).
Also see all insider trading activities at Johnson & Johnson.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | JNJ | 0 | $0 | 0 | $0 | 58,504 | $5,853,910 |
| 2024 | JNJ | 0 | $0 | 59,397 | $9,281,969 | 90,640 | $5,371,864 |
| 2023 | JNJ | 0 | $0 | 0 | $0 | 3,570 | $0 |
| 2022 | JNJ | 0 | $0 | 153,846 | $27,196,742 | 175,207 | $11,159,988 |
| 2021 | JNJ | 0 | $0 | 0 | $0 | 13,606 | $0 |
| 2020 | JNJ | 0 | $0 | 0 | $0 | 64,396 | $0 |
| 2019 | JNJ | 0 | $0 | 0 | $0 | 18,277 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-07 | JNJ | Option Ex | 58,504 | 100.06 | 5,853,910 |
| 2024-02-13 | JNJ | Option Ex | 1,302 | .00 | 0 |
| 2024-02-12 | JNJ | Option Ex | 26,202 | .00 | 0 |
| 2024-02-08 | JNJ | Option Ex | 3,739 | .00 | 0 |
| 2024-02-09 | JNJ | Option Ex | 59,397 | 90.44 | 5,371,864 |
| 2024-02-09 | JNJ | Sale | 59,397 | 156.27 | 9,281,969 |
| 2023-02-10 | JNJ | Option Ex | 3,570 | .00 | 0 |
| 2022-11-22 | JNJ | Option Ex | 76,923 | 72.54 | 5,579,994 |
| 2022-11-22 | JNJ | Sale | 76,923 | 176.78 | 13,598,371 |
| 2022-11-22 | JNJ | Option Ex | 76,923 | 72.54 | 5,579,994 |
| 2022-11-22 | JNJ | Sale | 76,923 | 176.78 | 13,598,371 |
| 2022-02-15 | JNJ | Option Ex | 18,064 | .00 | 0 |
| 2022-02-14 | JNJ | Option Ex | 3,297 | .00 | 0 |
| 2021-02-12 | JNJ | Option Ex | 13,606 | .00 | 0 |
| 2020-02-13 | JNJ | Option Ex | 16,084 | .00 | 0 |
| 2020-02-03 | JNJ | Option Ex | 48,312 | .00 | 0 |
| 2019-02-08 | JNJ | Option Ex | 8,529 | .00 | 0 |
| 2019-02-11 | JNJ | Option Ex | 9,748 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Taubert Jennifer L (EVP, WWC. Innovative Medicine of Johnson & Johnson at the time of this reporting) see the Securities and Exchange Commission (SEC) website.